Helen I. Torley

Overview

Helen I. Torley received an average of $6.2M in compensation at Halozyme Therapeutics from 2014 to 2018.

Source: SEC filings on March 22, 2019, March 22, 2018, and March 24, 2017.

Related executives

We found 18 more executives who work or worked at Halozyme Therapeutics.

Benjamin Hickey

Halozyme Therapeutics

Senior Vice President and Chief Commercial Officer

Laurie Stelzer

Halozyme Therapeutics

Chief Financial Officer

Harry Leonhardt

Halozyme Therapeutics

General Counsel

Dimitrios Chondros

Halozyme Therapeutics

Chief Medical Officer

Athena Countouriotis

Halozyme Therapeutics

Chief Medical Officer

Mark Gergen

Halozyme Therapeutics

Chief Operating Officer

David Ramsay

Halozyme Therapeutics

Chief Financial Officer

James Shaffer

Halozyme Therapeutics

Former Vice President and Chief Commercial Officer

News

You may also like